MATE

Pharmaceutical products, namely, modified antibodies and modified derivatives of antibodies that promote an immune response, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders